Literature DB >> 11839856

Non-T(H)1 cytokines are augmented systematically early in Guillain-Barré syndrome.

Rayomand Press1, V Ozenci, M Kouwenhoven, H Link.   

Abstract

The T(H)1 vs non-T(H)1 cytokine balance in Guillain-Barré syndrome (GBS) is unknown. Using enzyme-linked immunospot (ELISPOT) assays, we observed elevated numbers of interleukin (IL)-6 and IL-10-secreting blood mononuclear cells (BMNC) during the acute phase in untreated patients, and low levels of tumor necrosis factor alpha-secreting BMNC in the recovery phase of GBS. Numbers of IL-12p70-secreting BMNC were not affected over the course of GBS. The non-T(H)1 cytokine profile observed early in GBS may explain the self-limited clinical course associated with GBS.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11839856     DOI： 10.1212/wnl.58.3.476

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  9 in total

1.  Guillain-Barré syndrome after short-course efalizumab treatment.

Authors:  Marco Turatti; Stefano Tamburin; Domenico Idone; Maria Luigia Praitano; Giampietro Zanette
Journal:  J Neurol       Date:  2010-03-27       Impact factor: 4.849

2.  Bickerstaff brainstem encephalitis after heat stroke.

Authors:  Akiyuki Uzawa; Masahiro Mori; Noriko Tamura; Hirokatsu Takahashi; Hiroyuki Hirasawa; Takamichi Hattori; Satoshi Kuwabara
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

3.  Syndrome of Inappropriate Secretion of Antidiuretic Hormone Preceding Guillain-Barré Syndrome.

Authors:  Joe James; James Jose
Journal:  J Clin Diagn Res       Date:  2017-09-01

Review 4.  A review of the role of genetic factors in Guillain-Barré syndrome.

Authors:  Amin Safa; Tahereh Azimi; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-10-07       Impact factor: 3.444

5.  T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  P A Csurhes; A-A Sullivan; K Green; M P Pender; P A McCombe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 6.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

7.  Severe Acute Motor Axonal Neuropathy associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report.

Authors:  Oana Mosora; Laura Barcutean; Rodica Balasa; Raluca Fodor; Smaranda Maier; Zoltan Bajko; Adina Stoian; Anca Motataianu
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-11-06

Review 8.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

9.  Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.

Authors:  Shujuan Li; Tao Jin; Hong-Liang Zhang; Hong Yu; Fanhua Meng; Hernan Concha Quezada; Jie Zhu
Journal:  Mediators Inflamm       Date:  2014-05-12       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.